Table 2.
ACR.2 FM | ACR.2 FC | CTC FM | CTC FC | Phall FM | Phall FC | pY FM | pY FC | |
---|---|---|---|---|---|---|---|---|
ACR.2 FMa | 1 | 0.79 | 0.81 | 0.19 | 0.33 | 0.55 | 0.47 | 0.55 |
ACR.2 FCb | 0.79 | 1 | 0.69 | 0.17 | 0.33 | 0.62 | 0.39 | 0.44 |
CTC FMc | 0.81 | 0.69 | 1 | 0.25 | 0.35 | 0.59 | 0.52 | 0.47 |
CTC FCd | 0.19 | 0.17 | 0.25 | 1 | 0.24 | 0.31 | 0.12 | 0.23 |
Phall FMe | 0.33 | 0.33 | 0.35 | 0.24 | 1 | 0.47 | 0.27 | 0.35 |
Phall FCf | 0.55 | 0.62 | 0.59 | 0.31 | 0.47 | 1 | 0.23 | 0.29 |
anti-pY FMg | 0.47 | 0.39 | 0.52 | 0.12 | 0.27 | 0.23 | 1 | 0.71 |
anti-pY FCh | 0.55 | 0.44 | 0.47 | 0.23 | 0.35 | 0.29 | 0.71 | 1 |
r totali | 4.69 | 4.43 | 4.68 | 2.51 | 3.34 | 4.06 | 3.71 | 4.04 |
Correlation coefficients (r) between detections of capacitation status by individual detection methods
aFluorescent microscopy with anti-acrosin (ACR.2 FM) antibody
b Flow cytometry with ACR.2 antibody (ACR.2 FC)
cFluorescent microscopy with chlortetracycline (CTC FM)
dFlow cytometry with chlortetracycline (CTC FC)
eFluorescent microscopy with fluorescein isothiocyanate-conjugated phalloidin (Phall FM)
fFlow cytometry with fluorescein isothiocyanate-conjugated phalloidin (Phall FC)
gFluorescent microscopy with anti-phosphotyrosine antibody (anti-pY FM)
hFlow cytometry with anti-phosphotyrosine antibody (anti-pY FC)
iThe sum of correlation coefficients for appropriate detection method
Significant correlation coefficient in bold (p ≤ 0.05)